<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03468348</url>
  </required_header>
  <id_info>
    <org_study_id>SECI-IRB-IORG0006563-437</org_study_id>
    <nct_id>NCT03468348</nct_id>
  </id_info>
  <brief_title>Duloxetine for Acute Post-mastectomy Pain</brief_title>
  <official_title>Duloxetine for Acute Post-mastectomy Pain: Placebo Controlled Dose Ranging Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the analgesic effect of oral dulexitine tablet
      (administered 2 h before surgery) as well as the ideal dose for acute postmastectomy pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      patients undergoing mastectomy with axillary evacuation will be divided to four groups,
      Placebo group: received placebo capsule Duloxetine 30: received duloxetine 30 mg capsule
      Duloxetine 60: received duloxetine 60 mg capsule Duloxetine 90: received duloxetine 90 mg
      capsule the study medication is administered orall 2 h before surgery. Primary outcome
      variable: the first postoperative 24 h morphine consumption Secondary outcome: the VAS pain
      score measured every 4 h in the first 24 h postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">August 20, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the first postoperative 24 h (patient controlled analgesia [PCA])morphine consumption</measure>
    <time_frame>the first postoperative 24 hour</time_frame>
    <description>the cumulative patient controlled analgesia morphine consumption required by the patients to relieve their pain in the first postoperative 24 h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the intensity of pain measured by visual analogue pain scale (VAS)</measure>
    <time_frame>we will assess every 4 hour in the first postoperative 24 hour</time_frame>
    <description>the intensity of pain measured by visual analogue pain scale (VAS) in which 0 = no pain and 10 = the maximum imaginable pain</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Acute Pain</condition>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>duloxetine 30</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>duloxetine 60</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>duloxetine 90</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Duloxetine</intervention_name>
    <description>patients scheduled for mastectomy and axillary evacuation for cancer breast will receive orally, 2 hours before the operation either, placebo capsule, duloxetine 30 mg,duloxetine 60 mg or duloxetine 90 mg capsule.</description>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_label>duloxetine 30</arm_group_label>
    <arm_group_label>duloxetine 60</arm_group_label>
    <arm_group_label>duloxetine 90</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing mastectomy with axillary evacuation for cancer breast

        Exclusion Criteria:

          -  patient refusal

          -  uncontrolled hypertension and ischemic heart disease

          -  patients treated with chronic pain medications such as, non steroidal
             anti-inflammatory, pregabalin and opioids
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Diab Hetta, MD</last_name>
    <phone>+201091090009</phone>
    <email>diabhetta25@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diab</name>
      <address>
        <city>Assiut</city>
        <state>Assuit</state>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diab Hetta, MD</last_name>
      <phone>+201091090009</phone>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2018</study_first_submitted>
  <study_first_submitted_qc>March 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Diab Fuad Hetta</investigator_full_name>
    <investigator_title>principle investigator</investigator_title>
  </responsible_party>
  <keyword>duloxetine</keyword>
  <keyword>mastectomy</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Duloxetine Hydrochloride</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

